Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Hepatitis C, Chronic 1Hepatitis C 1Fibrosis 1Diabetes Mellitus 1Cardiovascular Diseases 1Carcinoma, Hepatocellular 1

Interventions

Specimen Handling 191Magnetic Resonance Spectroscopy 141Biopsy 102pembrolizumab 85Carboplatin 79Cisplatin 71Nivolumab 64Paclitaxel 52Radiotherapy 51Gemcitabine 51Cyclophosphamide 48Dexamethasone 47durvalumab 39Radiation 39atezolizumab 38Pemetrexed 38olaparib 34Rituximab 34venetoclax 33Etoposide 33Lenalidomide 32Doxorubicin 32Bevacizumab 32X-Rays 30Prednisone 30Docetaxel 30Disulfides 28Ipilimumab 27Immunoglobulin G 27Fluorouracil 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × sofosbuvir-velpatasvir drug combination × 30 days × Clear all
NCT03520660 2026-06-03

People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents

National Institutes of Health Clinical Center (CC)

Phase 4 Active not recruiting
121 enrolled
Gastrointestinal

Cardiovascular Diseases, Diabetes Mellitus, Fibrosis, Hepatitis C, Carcinoma, Hepatocellular, Hepatitis C, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡